You searched for "funding"
Lenire®, the tinnitus treatment device, now available in Norway
Neuromod Devices Ltd., has reached an agreement with HØR AS, Norway’s largest private provider of hearing and tinnitus care, to make its Lenire tinnitus treatment device available in Norway.Neuromod advances multiple regulatory approvals to expedite Lenire’s global availability
Neuromod, the medical technology company that created the Lenire® tinnitus treatment device, has announced approval to the Medical Device Single Audit Program (MDSAP) and EU Medical Device Regulation (MDR) certification. Neuromod’s MDSAP certification follows a comprehensive audit verifying compliance with...Expanding audiology into sleep health
ENT & Audiology News distribution partner, The Listening Lab Group, has identified a recurring pattern across its clinics in Malaysia and Singapore that has become increasingly difficult to ignore. Patients presenting with hearing-related concerns – particularly tinnitus – often describe...ENT In this issue...Landmark Papers that Defined ENT and Audiology
In 2018, I compiled a book with the title Landmark Papers in Otolaryngology. The book was inspired by the ENT department journal club that regularly took place in a local Norwich pub, and it discusses 99 of the most cited papers in the ENT and audiology literature.
Voice after posterior cordotomy: we think voice is bad, patients think it’s better!
Bilateral vocal fold immobility (BVFI) is a condition that can affect voice with an impact on quality of life (QOL). Surgical trauma from damage to bilateral recurrent laryngeal nerves, such as from previous thyroid, parathyroid, or mediastinal surgery are common...
Is clinical HIT as good as vHIT in the emergency room?
Establishing the cause of acute vestibular syndrome (AVS) is critical in the first few hours of presentation in the emergency department. The first question to ask is, “is it due to a peripheral vestibular pathology or a stroke?” This is...
Hearing difficulties and memory problems
Since the Lancet Commission report in 2020, we have all been aware that untreated hearing loss is potentially one of the biggest modifiable risk factors for dementia in midlife. Hearing loss is also associated with other risk factors for dementia,...
Case study suggesting mtDNA mutation as a tinnitus factor: ND1:m.3394T>C
Konadath et al report a genetic case study of a 24-year-old female experiencing reduced hearing sensitivity and tinnitus along with a blocked sensation in her right ear, sudden onset one year prior with no other otological complaints. Standard audiometry along...
Temperature-controlled radiofrequency treatment of the nasal valve confers sustained benefit
Aiming to investigate long-term efficacy and safety (three years post treatment), this was an extension of a previous multicentre, prospective, single-blinded, randomised controlled trial that investigated the effectiveness and safety of temperature-controlled radiofrequency treatment (TCRF) to the nasal valve (NV)...Audiovestibular findings in children with enlarged vestibular aqueduct
Enlarged vestibular aqueduct is reported to affect up to 15% of the paediatric population with sensorineural hearing loss. Devin McCaslin and Bridget Smith provide an up-to-date overview of the mechanisms and clinical symptoms underlying the condition and share some of...
